価格表

在庫・価格 : 2026年03月15日 05時19分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Trial Kit in vivo Polymag
データシート
IV-TK30210 OZBオズ バイオサイエンス
OZ Biosciences
1 kit ¥51,000
(未発注)
追加

在庫・価格 : 2026年03月15日 05時19分 現在

Trial Kit in vivo Polymag

  • 商品コード:IV-TK30210
  • メーカー:OZB
  • 包装:1kit
  • 価格: ¥51,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Ohashi K et al. Neuron-derived neurotrophic factor functions as a novel modulator that enhances endothelial cell function and revascularization processes. J. Biol. Chem. 2014 May;289(20):14132-44
Ohashi K et al
2014/01/01
PubMed
2 Kurena B et al. Magnetic nanoparticles for efficient cell transduction with Semliki Forest virus. J. Virol. Methods 2017 Jul;245:28-34
Kurena B et al
2017/01/01
PubMed
3 Singh J et al. In vivo magnetofection: a novel approach for targeted topical delivery of nucleic acids for rectoanal motility disorders. Am. J. Physiol. Gastrointest. Liver Physiol. 2017 Oct;:ajpgi.00233.2017
Singh J et al
2017/01/01
PubMed
4 H端ttinger C et al. Neoadjuvant gene delivery of feline granulocyte-macrophage colony-stimulating factor using magnetofection for the treatment of feline fibrosarcomas: a phase I trial. J Gene Med 2008 Jun;10(6):655-67
H端ttinger C et al
2008/01/01
PubMed
5 Jahnke A et al. Intra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I study. J Vet Med A Physiol Pathol Clin Med 2007 Dec;54(10):599-606
Jahnke A et al
2007/01/01
PubMed
6 Brenner TK et al. Evaluation of BMP2/miRNA co-expression systems for potent therapeutic efficacy in bone-tissue regeneration. Eur Cell Mater 2021 03;41:245-268
Brenner TK et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Ohashi K et al. Neuron-derived neurotrophic factor functions as a novel modulator that enhances endothelial cell function and revascularization processes. J. Biol. Chem. 2014 May;289(20):14132-44
    Ohashi K et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Kurena B et al. Magnetic nanoparticles for efficient cell transduction with Semliki Forest virus. J. Virol. Methods 2017 Jul;245:28-34
    Kurena B et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Singh J et al. In vivo magnetofection: a novel approach for targeted topical delivery of nucleic acids for rectoanal motility disorders. Am. J. Physiol. Gastrointest. Liver Physiol. 2017 Oct;:ajpgi.00233.2017
    Singh J et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    H端ttinger C et al. Neoadjuvant gene delivery of feline granulocyte-macrophage colony-stimulating factor using magnetofection for the treatment of feline fibrosarcomas: a phase I trial. J Gene Med 2008 Jun;10(6):655-67
    H端ttinger C et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Jahnke A et al. Intra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I study. J Vet Med A Physiol Pathol Clin Med 2007 Dec;54(10):599-606
    Jahnke A et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Brenner TK et al. Evaluation of BMP2/miRNA co-expression systems for potent therapeutic efficacy in bone-tissue regeneration. Eur Cell Mater 2021 03;41:245-268
    Brenner TK et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed